96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Chimeric peptide that interacts with cell membrane gangliosides
#2402Ribosomes with tethered subunits
#2403Methods of treatment using hemopexin compositions
#2404Sequences associated with TDP-43 proteinopathies and methods of using the same
#2405Antibodies specific for sulfation sites of sclerostin
#2406LIPOCALIN MUTEINS WITH BINDING-AFFINITY FOR GLYPICAN-3 (GPC-3) AND USE OF LIPOCALIN MUTEINS FOR TARGET-SPECIFIC DELIVERY TO CELLS EXPRESSING GPC-3
#2407Opsin polypeptides and methods of use thereof
#2408Continuous process for separation of proteins
#2409Polypeptides and Antibodies for Assessing Predisposition for Myelodysplastic Syndromes or Myelogenous Tumor, and Method for Screening Therapeutic Drugs Therefor
#2410Eukaryotic cells and methods for recombinantly expressing a product of interest
#2411APLNR modulators and uses thereof
#2412Heterogeneous nuclear ribonucleoprotein A2* (hnRNP A2*) and nucleic acid encoding the same
#2413Self-assembled beta solenoid protein scaffolds
#2414Composition for organ, tissue, or cell transplantation, kit, and transplantation method
#2415Antimicrobial agents
#2416Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases
#2417Methods for treating myocardial infarction comprising administering sonic hedgehog
#2418Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
#2419Mirac proteins
#2420Integrin Antagonists
#2421Protein secretory factor with high secretory efficiency and an expression vector comprising the same
#2422Human Sperm Fibrous Sheath (FS) Proteins: New Target Antigens For Use In Therapeutic Cancer Vaccines And Diagnostic Screening And Methods Of Using Same
#2423RNA containing modified nucleosides and methods of use thereof
#2424Isoform nell-1 peptide
#2425Fibronectin binding domains with reduced immunogenicity
#2426NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
#2427Extended recombinant polypeptides and compositions comprising same
#2428Characterization and Directed Evolution of a Methyl Binding Domain Protein for High-Sensitivity DNA Methylation Analysis
#2429Compositions and methods for making selenocysteine containing polypeptides
#2430High molecular weight, post-translationally modified protein brushes
#2431Fusion molecules
#2432HLA-A2 tumor associated antigen peptides and compositions
#2433Biomarker pairs for predicting preterm birth
#2434Method of culturing pluripotent stem cell, and polypeptide to be used therefor
#2435Methods and compositions comprising tau oligomers
#2436Peptides derived from NCAPG2 and their use
#2437Biomarker for parkinson's disease and use thereof
#2438Methods for detecting levels of pigment epithelium-derived factor and antithrombin-III for characterising and/or prognosing prostate cancer
#2439Production of Therapeutic Proteins in Photosynthetic Organisms
#2440Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
#2441Amelogenin-chitosan hydrogel for dentin hypersensitivity
#2442Anti-C5a binding moieties with high blocking activity
#2443EphA2 T-cell epitope agonists and uses therefore
#2444Brown adipocyte modification
#2445Substituted pyrazoles as heat shock transcription factor activators
#2446Kidney-specific tumor vaccine directed against kidney tumor antigen G-250
#2447Cell culture medium and culture method using the same
#2448Fc fusion proteins comprising novel linkers or arrangements
#2449Peptides and compositions for treatment of joint damage
#2450Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#2451Modified polynucleotides for the production of secreted proteins
#2452Methods for treating cancer by inhibiting FGFR3/TACC3 fusion protein
#2453Protein hydrolysate and method for making a protein hydrolysate
#2454Colostrum/milk protein compositions
#2455RNA preparations comprising purified modified RNA for reprogramming cells
#2456Glycosylated polypeptide and drug composition containing said polypeptide
#2457Method of preventively treating a subject at the risk of developing infections of a respiratory virus
#2458Compound, use, anti-tumor pharmaceutical composition, gene construct for polypeptide expression, process for the production, process for the evaluation of tumor cells, method of sensitization of tumor cells to chemotherapeutic
#2459Peptide having cancer selective translocation function and use thereof
#2460Selective arylation of dichalcogenides in biomolecules
#2461CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS
#2462Modification and compositions of human secretoglobin proteins
#2463KIDNEY DISEASE TARGETS AND USES THEREOF
#2464Multi-specific polypeptide useful for localized tumor immunomodulation
#2465Recombinant binding proteins and their use
#2466COSMETIC USE OF DERMICIDIN, OR ANALOGUES OR FRAGMENTS THEREOF, FOR THE PREVENTION AND/OR TREATMENT AND DIAGNOSIS OF OILY SKIN AND AESTHETIC SKIN DISORDERS ASSOCIATED THEREWITH
#2467Methods and compositions for targeting polyubiquitin
#2468Methods for treatment of nephrotic syndrome and related conditions
#2469Method for improving protein functionality using vortexing fluid shear forces
#2470Device and method for production and analysis of prions
#2471Venule endothelial cell genes and uses thereof
#2472Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)
#2473Interaction of draxin and γ-netrins
#2474Short peptide-based therapeutic agent and medicinal composition including the same for inhibiting activities of cancer cells
#2475Compositions and methods to modulate cell activity
#2476Pharmaceutical compositions containing peptides derived from human BPLP protein
#2477RECURRENT FUSION GENES IDENTIFIED IN HIGH -GRADE SEROUS OVARIAN CARCINOMA
#2478Wound healing compositions and treatments
#2479Animal model and cell model developing amyotrophic lateral sclerosis
#2480Method and means for diagnosing and treating allergy
#2481SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF
#2482INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#2483Peptide having cell membrane penetrating activity
#2484DNA vaccine against virus of Yellow Fever
#2485Pharmaceutical compositions targeting WNT pathway proteins
#2486Methods and compositions for generating a mouse
#2487EGFR-based inhibitor peptides for combinatorial inactivation of ERBB1, ERBB2, and ERBB3
#2488Three-helix bundle protein and use thereof
#2489Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#2490Resistant mutant 90 kDa heat shock protein
#2491Stable polypeptides binding to human complement C5
#2492Production cell line enhancers
#2493Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#2494Targeted augmentation of nuclear gene output
#2495Dpy-30 binding peptides and methods of use
#2496Exposure dose homogenization through rotation, translation, and variable processing conditions
#2497METHODS FOR DETECTING TRAUMATIC BRAIN INJURY
#2498Polypeptides
#2499Antibodies that specifcally bind Sost and Wise peptides
#2500ALK4:ActRIIB heteromultimers and uses thereof
#2501Selective PYY compounds and uses thereof
#2502Synthesis of hydantoin containing peptide products
#2503Compositions and methods for cardiac regeneration
#2504Methods of treating cancers with peptide-based modulators
#2505METHODS OF DIAGNOSING CANCER
#2506Lung cancer diagnosis
#2507Biocatalysts for ezetimibe synthesis
#2508Peptides and combination of peptides for use in immunotherapy against various tumors
#2509Peptides and combination of peptides for use in immunotherapy against various tumors
#2510Peptides and combination of peptides for use in immunotherapy against various tumors
#2511Peptides and combination of peptides for use in immunotherapy against various tumors
#2512Biologically active proteins having increased in vivo and/or in vitro stability
#2513Peptides and combination of peptides for use in immunotherapy against various tumors
#2514ANTICALINS
#2515Peptides and combination of peptides for use in immunotherapy against various tumors
#2516Peptides and combination of peptides for use in immunotherapy against various tumors
#2517NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2518NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2519Peptides and combination of peptides for use in immunotherapy against various tumors
#2520Amylin analogues
#2521CDCA1 epitope peptides and vaccines containing the same
#2522Nucleic acids for treatment of allergies
#2523Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cell
#2524Modified binding proteins inhibiting the VEGF-A receptor interaction
#2525Proteasome inhibition assay and methods of use
#2526Chloroplast expressing colostrum or milk polypeptides
#2527PROTOXIN-II VARIANTS AND METHODS OF USE
#2528BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF
#2529Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein
#2530Scaffold-free self-organized 3D synthetic tissue
#2531Muteins of tear lipocalin and methods for obtaining the same
#2532Designed ankyrin repeat proteins binding to hepatocyte growth factor
#2533Lipid co-factor essential for cell density signaling
#2534Designed repeat proteins binding to serum albumin
#2535Immunoregulatory peptides and methods of use
#2536Use of endostatin peptides for the treatment of fibrosis
#2537VEGF antagonist formulations suitable for intravitreal administration
#2538HCBI sequences as an early marker for the future development of cancer and diseases of the CNS and as a target for cancer treatment and prevention
#2539Peptides and compositions for treatment of joint damage
#2540Pumilio domain-based modular protein architecture for RNA binding
#2541Method of generating linkage-specific di-and polyprotein probes
#2542Nucleic acids encoding polypeptides which disrupt D1-D2 dopamine receptor coupling and modulate function
#2543Apelin fusion proteins and uses thereof
#2544Mitochondrial targeting and therapeutic use thereof
#2545Fluorescent protein
#2546Assay for the detection of the phenylpiperazine family
#2547Therapy for subarachnoid hemorrhage and ischemia
#2548Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#2549Nuclear targeting sequences
#2550Isolated B7-H4 specific compositions and methods of use thereof
#2551Opsin polypeptides and methods of use thereof
#2552Universal protein tag for double stranded nucleic acid delivery
#2553Substituted pyrazoles as heat shock transcription factor activators
#2554COMBINATIONS OF AGGREGATING PROTEINS AND MOLECULAR CHAPERONE PROTEINS FOR THE TREATMENT OF PROTEINOPATHIES OR CONFORMATIONAL DISEASES
#2555IL-1beta propeptide and IL-1Ra chimera and methods of using the same
#2556Influenza nucleoprotein vaccines
#2557METHOD OF TREATING DISORDERS REQUIRING DESTRUCTION OR REMOVAL OF CELLS
#2558Fused cyclooctyne compounds and their use in metal-free click reactions
#2559PLIF multimeric peptides and uses thereof
#2560USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION
#2561Synthetic apelin fatty acid conjugates with improved half-life
#2562VEGF antagonist formulations suitable for intravitreal administration
#2563Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#2564Peptides inhibiting cold-inducible RNA binding protein activity
#2565Engineered integrin binding peptide compositions
#2566Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
#2567Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
#2568Modified mini-hepcidin peptides and methods of using thereof
#2569Modified polynucleotides for the production of proteins associated with human disease
#2570Polypeptide targeting to mitochondria
#2571Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP
#2572Immunogenic peptides and their use in immune disorders
#2573Treating cancer with a combination of a PD-1 antagonist and dinaciclib
#2574Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl
#2575Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#2576Modified cascade ribonucleoproteins and uses thereof
#2577MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#2578Screening method for inhibitors of binding of zBR7R1 to CD155
#2579Protein engineered systems for delivery of molecules
#2580Peptides
#2581Compositions and methods for treatment of disorders related to CEP290
#2582Class of therapeutic protein based molecules
#2583Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein
#2584BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
#2585RASAL1 is a major tumor suppressor gene in thyroid cancer
#2586Resonance energy transfer assay with cleavage sequence and spacer
#2587Partial region polypeptide of REIC/Dkk-3 protein
#2588Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof
#2589Methods for treating or preventing fatty liver disease using CTRP3
#2590METHODS FOR IDENTIFYING AUTOIMMUNE ARTHRITIS AND FOR SCREENING FOR INHIBITOR OF ACTIVATION OF AUTOIMMUNE ARTHRITOGENIC T CELLS
#2591TRANSDUCIBLE MATERIALS FOR CELL REPROGRAMMING
#2592Method of treating myocardial infarction by administering a bi-specific fusion protein
#2593TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES
#2594COMPOSITIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
#2595Antibody multimerization technologies
#2596Methods of treating chronic inflammatory diseases
#2597Methods and compositions for treating and diagnosing diseases
#2598Identification, selection and use of high curative potential T cell epitopes
#2599Coiled coil immunoglobulin fusion proteins and compositions thereof
#2600Cyclic apelin derivatives for the treatment of heart failure
#2601Compositions and methods of use for recombinant human secretoglobins
#2602Strigolactone formulations and uses thereof
#2603Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#2604METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS
#2605Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis
#2606Dispersion and detachment of cell aggregates
#2607Reagents and methods for treating dental disease
#2608Modified polynucleotides for the production of proteins
#2609Botulinum neurotoxins with modified light chain specificity and methods for producing same
#2610Development and use of cysteine-labeled fluorescent probes of unbound analytes
#2611NOVEL BIOMARKER DETECTION WITH MOLECULAR IMPRINTS
#2612CETP antigenic peptide and fusion protein and their composition and applications
#2613Disulfide cyclic polypeptides for the treatment of heart failure
#2614Myonectin (CTRP15), compositions comprising same, and methods of use
#2615METHODS AND CHARACTERISTICS FOR THE DIAGNOSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA
#2616Methods for the expression of peptides and proteins
#2617COLON DISEASE TARGETS AND USES THEREOF
#2618mda-9/syntenin promoter to image and treat metastatic cancer cells
#2619MESSENGER UNA MOLECULES AND USES THEREOF
#2620Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#2621Bis-Met histones
#2622Bis-met histones
#2623IgG4 Fc fragment comprising modified hinge region
#2624Small mobile stem cells (SMS) and uses thereof
#2625Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
#2626CARTILAGE-BINDING FUSION PROTEINS
#2627Compositions and methods for modulation of immune function
#2628GHRELIN SPLICE VARIANT FOR TREATING NEURONAL DAMAGE,NEURODEGENERATIVE DISEASE, PARKINSONS DISEASE, ALZHEIMERS DISEASE, AND/OR DEPRESSION
#2629RETRO POLYPEPTIDES FOR ACTIVATION IMMUNITY TO CANCER AND VIRAL INFECTION
#2630Agents for preventing and treating HIV and other viral infections
#2631Inhibitors of mitochondrial fission and methods of use thereof
#2632VP16-CREB fusion gene
#2633Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)
#2634Colorimetric and fluorescent proteins
#2635CERBERUS/COCO DERIVATIVES AND USES THEREOF
#2636Recombinantly produced allergens
#2637Modified polynucleotides for the production of nuclear proteins
#2638TAFA4 compounds and uses thereof for treating pain
#2639-Prom mediated surface expression of avidin/streptavidin
#2640Method for inhibiting HIV replication in mammal and human cells
#2641Fusion proteins and methods thereof
#2642Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same
#2643Vectors encoding rod-derived cone viability factor
#2644THERAPEUTIC PEPTIDES
#2645Cyclic polypeptides for the treatment of heart failure
#2646Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification
#2647Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
#2648Infectious hepatitis E virus genotype 3 recombinants
#2649Novel Peptides Involved in Energy Homeostasis
#2650Viral vectors for the treatment of retinal dystrophy
#2651Internal protein tags
#2652Compositions of active Wnt protein
#2653Methods for producing peptides using engineered inteins
#2654Methods and Reagents for Treatment of Age-Related Macular Degeneration
#2655CHONDROADHERIN FRAGMENTS AS INDICATORS OF INTERVERTEBRAL DISC DEGENERATION
#2656Methods of using U2-OS cells to identify potential sweet taste modulators
#2657Antiviral agent against animal viruses
#2658Methods and systems for zinc delivery using intrinsic factor or haptocorrin
#2659Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect - Cell-Permeable Trefoil Factor 1 (CP-TFF1) in Gastrointestinal Track (GIT) Cancer, Polynucleotides Encoding The Same, and Anti-Cancer Compositions Comprising The Same
#2660Follistatin in treating duchenne muscular dystrophy
#2661Horse allergen and methods
#2662Methods and compositions for treating trinucleotide repeat disorders
#2663Humanin, analogs and cancer treatment methods and uses thereof
#2664In vitro production of red blood cells with proteins comprising sortase recognition motifs
#2665Probes and assays for measuring E3 ligase activity
#2666Human serum albumin binding compounds and fusion proteins thereof
#2667Capping modules for designed ankyrin repeat proteins
#2668Aquaporin-4 Peptide Compositions and Methods of Use
#2669Method for producing protein
#2670Mitochondrial proteins constructs and uses thereof
#2671Modified polynucleotides for the production of biologics and proteins associated with human disease
#2672CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS
#2673MOLECULAR LABELING METHODS
#2674Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#2675Stablized EZH2 peptides
#2676Trap 63
#2677Modified proteins and methods of use thereof
#2678Bone substitute nanocomposites and methods of synthesis using multiphosphorylated peptides
#2679Improved Gene Targeting and Nucleic Acid Carrier Molecule, In Particular for Use in Plants
#2680Frataxin mutants
#2681Therapeutic DLL4 binding proteins
#2682ISOLATED CLATHRIN THERAPEUTICS
#2683Endoplasmic reticulum localization signals
#2684Human ferritin-derived fusion polypeptide
#2685Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides
#2686Immunogenic epitopes for immunotherapy
#2687Anti-angiogenic peptides and uses thereof
#2688METHODS FOR TREATMENT OF CARDIOMYOPATHY
#2689Stabilized SOS1 peptides
#2690Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide
#2691Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection
#2692Delivery of polynucleotides using recombinant AAV9
#2693Immunogenic compositions for inducing an immune response for elimination of senescent cells
#2694Methods for Treating Mitochondrial Disorders and Neurodegenerative Disorders
#2695Water buffalo derived dimeric peptide containing proline for antibiotic therapies
#2696RHAMM binding peptides
#2697Immunity inducing agent
#2698Synthetic peptides for the treatment of autoimmune diseases
#2699Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
#2700Methods of treating damaged cartilage tissue using growth factors fused to heparin binding sequences